| ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers E Tacconelli, F Mazzaferri, AM de Smet, D Bragantini, P Eggimann, ... Clinical microbiology and infection 25 (7), 807-817, 2019 | 185 | 2019 |
| Human dose response relation for airborne exposure to Coxiella burnetii RJ Brooke, MEE Kretzschmar, NT Mutters, PF Teunis BMC infectious diseases 13, 1-8, 2013 | 124 | 2013 |
| Bed occupancy rates and hospital-acquired infections—should beds be kept empty? K Kaier, NT Mutters, U Frank Clinical microbiology and infection 18 (10), 941-945, 2012 | 112 | 2012 |
| SARS-CoV-2 in environmental samples of quarantined households M Döhla, B Schulte, G Wilbring, BM Kümmerer, C Döhla, E Sib, E Richter, ... Viruses 14 (5), 1075, 2022 | 110 | 2022 |
| Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance NT Mutters, V Mersch-Sundermann, R Mutters, C Brandt, ... Deutsches Ärzteblatt International 110 (43), 725, 2013 | 107 | 2013 |
| Performance of Kiestra total laboratory automation combined with MS in clinical microbiology practice NT Mutters, CJ Hodiamont, MD de Jong, HPJ Overmeijer, ... Annals of laboratory medicine 34 (2), 111, 2014 | 102 | 2014 |
| STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship E Tacconelli, MA Cataldo, M Paul, L Leibovici, J Kluytmans, W Schröder, ... BMJ open 6 (2), e010134, 2016 | 94 | 2016 |
| Contact Precautions for Preventing Nosocomial Transmission of Extended-Spectrum β Lactamase–Producing Escherichia coli: A Point/Counterpoint Review S Tschudin-Sutter, JC Lucet, NT Mutters, E Tacconelli, JR Zahar, ... Clinical infectious diseases 65 (2), 342-347, 2017 | 90 | 2017 |
| Natural isothiocyanates express antimicrobial activity against developing and mature biofilms of Pseudomonas aeruginosa SJ Kaiser, NT Mutters, B Blessing, F Günther Fitoterapia 119, 57-63, 2017 | 84 | 2017 |
| Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries JA Otter, NT Mutters, E Tacconelli, A Gikas, AH Holmes Clinical Microbiology and Infection 21 (12), 1057-1066, 2015 | 84 | 2015 |
| Compliance with infection control practices in an university hospital dental clinic NT Mutters, U Hägele, D Hagenfeld, E Hellwig, U Frank GMS hygiene and infection control 9 (3), 2014 | 75 | 2014 |
| Healthcare workers’ knowledge, attitudes and behaviours with respect to antibiotics, antibiotic use and antibiotic resistance across 30 EU/EEA countries in 2019 D Ashiru-Oredope, S Hopkins, S Vasandani, E Umoh, O Oloyede, ... Eurosurveillance 26 (12), 1900633, 2021 | 72 | 2021 |
| Detection of a cfr(B) Variant in German Enterococcus faecium Clinical Isolates and the Impact on Linezolid Resistance in Enterococcus spp. JK Bender, C Fleige, I Klare, S Fiedler, A Mischnik, NT Mutters, KE Dingle, ... PLoS One 11 (11), e0167042, 2016 | 70 | 2016 |
| Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patients I Klare, C Fleige, U Geringer, A Thürmer, J Bender, NT Mutters, ... Journal of global antimicrobial resistance 3 (2), 128-131, 2015 | 63 | 2015 |
| Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilities M Falcone, M Paul, D Yahav, G Orlando, G Tiseo, V Prendki, ... Clinical Microbiology and Infection 25 (5), 562-569, 2019 | 55 | 2019 |
| Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey C Pulcini, G Tebano, NT Mutters, E Tacconelli, E Cambau, G Kahlmeter, ... International journal of antimicrobial agents 49 (2), 162-166, 2017 | 53 | 2017 |
| Comparison of livestock-associated and health care–associated MRSA—genes, virulence, and resistance NT Mutters, CP Bieber, C Hauck, G Reiner, V Malek, U Frank Diagnostic microbiology and infectious disease 86 (4), 417-421, 2016 | 47 | 2016 |
| Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & discovery of new antibiotics in European countries NB Rajendran, NT Mutters, G Marasca, M Conti, F Sifakis, C Vuong, ... Clinical microbiology and infection 26 (7), 943. e1-943. e6, 2020 | 45 | 2020 |
| A one health framework to estimate the cost of antimicrobial resistance CM Morel, RA Alm, C Årdal, A Bandera, GM Bruno, E Carrara, ... Antimicrobial Resistance & Infection Control 9, 1-14, 2020 | 44 | 2020 |
| Antimicrobials Are a Photodynamic Inactivation Adjuvant for the Eradication of Extensively Drug-Resistant Acinetobacter baumannii A Wozniak, A Rapacka-Zdonczyk, NT Mutters, M Grinholc Frontiers in microbiology 10, 229, 2019 | 43 | 2019 |
